Symtuza 150 mg/1
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide · TABLET, FILM COATED · Janssen Products LP
Symtuza is a combination tablet taken by mouth that contains four active ingredients used to treat HIV infection. It works by inhibiting viral replication through multiple mechanisms to help reduce the amount of HIV in the body.
Key Facts
- Brand Name
- Symtuza
- Generic Name
- Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide
- NDC Code (Product)
59676-800- Manufacturer
- Janssen Products LP
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210455
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]; Protease Inhibitor [EPC]
- Marketing Start
- 07/17/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Symtuza used for?
Symtuza is a combination tablet taken by mouth that contains four active ingredients used to treat HIV infection. It works by inhibiting viral replication through multiple mechanisms to help reduce the amount of HIV in the body.
Is Symtuza a controlled substance?
Symtuza is not classified as a controlled substance by the DEA.
What is the generic name for Symtuza?
The generic name for Symtuza is Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide. There are no other listed brand versions of Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide.
What is the NDC code for Symtuza 150 mg/1?
The NDC (National Drug Code) for Symtuza 150 mg/1 is 59676-800, listed by Janssen Products LP.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)